Skip to content
Agentic OS
Menu

Intelligence / Healthtech / Health Funding Register / Superluminal Medicines, Inc.

Fundingraised $65.5M3 Sept 2026

Superluminal Medicines, Inc.

3 Sept 2026: Raised $65.5M · Boston, MA. Recorded in the SEC Form D data sets.

View the source record

Filed
3 Sept 2026
Location
Boston, MA
State
Massachusetts
Industry
Biotechnology
Amount raised
$65.5M
Offering size
$65.5M
Revenue range
Decline to Disclose
Year of incorporation
2023
Entity type
Corporation
Jurisdiction
Delaware
First sale
2026-08-10
Securities
Equity
Investors so far
16
SEC CIK
0001989478
What this signal means

Companies buy in the months after they raise: new hires, new vendors, new markets.

  1. 137 added in the 30 days to 30 Sept 2026.
  2. 114 of them (29%) raised $5M or more.
Reach them with AOS

Find the decision makers at Superluminal Medicines, Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this funding signal, for your approval.

Start free

Across AOS Research

Other records for Superluminal Medicines, Inc. in our registers.

More from Massachusetts

Health Funding Register

See all

Source: SEC Form D data sets, data to 30 Sept 2026. New Form D notices filed in Q3 2026 by health and life-sciences companies; pooled investment funds and amendments excluded. Amounts are as reported to the SEC. AOS shows what the public record says; it does not verify or endorse the company.